The Rome Cohort, page-7

First 7 Last

Share
Profile

Follow
Uboy

4,683 Posts.

1086

06/10/20

11:07

Post #: 47876945
Share

Originally posted by waynesworld ↑

From the patients and parents perspective it doesn't matter whether the therapy is exon-skipping or gene therapy, whether its steroids or other anti inflammatory treatments. What actually matters is whether the medication is effective in improving quality of life and increasing life span without nasty side effects. Outside of a cure, its the ability to be self sufficient in the little things of life and gain enjoyment from daily activities that we all take for granted. So, PUL 2.0 is a proxy measurement for all those things.

Just as ANP can compare the mean change for the nine boys in their Phase II trial against the Rome Cohort, so too can Pharma/Biotech compare their drugs performance against ATL1102. There is a presentation Performance of Upper Limb Measure: PUL 2.0 made to the PPMD Conference in June 2016. Just for some context, before PUL 2.0 there was PUL 1.2; simply put PUL 2.0 is a refinement of PUL 1.2 to improve PUL's measurement properties and ease and clarity of testing. I wanted to highlight one slide titled Studies Using PUL. Its a list of Pharma/Biotech including Sarepta who use either PUL 1.2 or PUL 2.0 in studies. Remember this is from a presentation in 2016 so it would be interesting to see an update.

I mention the slide because it highlights the importance of PUL as an endpoint. I suspect that the announcement by ANP of comparison with a matched natural history control is of far greater importance than at first glance: the audience includes shareholders but will speak more loudly to advocacy groups, clinicians and pharmaceutical and biotech companies operating in the space.

It also begs the following question. What would be the PUL 2.0 results once an optimal dose for ATL1102 is established and what would be the PUL 2.0 results in combination therapy using ATL1102 and exon skipping or gene therapy drug?

Expand

Thanks Wayne,

Something more recent....

Capricor came out in May with their P2 PUL2.0 results: a mean loss in PUL2 over the 12 months of -1.3

Now the Rome cohort with natural history PUL mean was -2.0

ATL1102 comes in at +0.9 in only 6 months.

Capricor have a meeting with FDA later this year re next steps....guessing they're trying Fast Track route to use P2 results.

Our data is good!

ANP Price at posting: 10.5¢ Sentiment: Buy Disclosure: Held
11 Upvote

1 Great analysis

Reply

Top Stories

SS1

Sun Silver to kick off drilling next week at 292Moz Maverick Springs silver-gold project

AHK

Ark Mines inks 1.5Bt Exploration Target for Sandy Mitchell REE play including NdPr; PFS due in Q4

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

SVM

Sovereign's Kasiya project gains momentum, as Rio increases investment by 19.76%

Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25

There are more pages in this discussion • 74 more messages in this thread...

First 7 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 8.4¢		Change 0.004(5.00%)		Mkt cap ! $75.72M

Open	High	Low	Value	Volume
8.0¢	8.4¢	8.0¢	$25.89K	316.1K

Buyers (Bids)

No.	Vol.	Price($)
2	27713	8.2¢

Sellers (Offers)

Price($)	Vol.	No.
8.3¢	5470	1

View Market Depth

No.	Vol.	Price($)
2	27713	0.082
1	118618	0.079
2	212658	0.078
1	20000	0.077
2	85000	0.076

Price($)	Vol.	No.
0.083	5470	1
0.084	66565	1
0.085	106431	2
0.086	100000	1
0.087	125000	1

Last trade - 10.37am 03/07/2024 (20 minute delay)

PER (ASX) Chart

The Rome Cohort, page-7

Sun Silver to kick off drilling next week at 292Moz Maverick Springs silver-gold project

Ark Mines inks 1.5Bt Exploration Target for Sandy Mitchell REE play including NdPr; PFS due in Q4

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Sovereign's Kasiya project gains momentum, as Rio increases investment by 19.76%

Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

The Rome Cohort, page-7

Top Stories

Sun Silver to kick off drilling next week at 292Moz Maverick Springs silver-gold project

Ark Mines inks 1.5Bt Exploration Target for Sandy Mitchell REE play including NdPr; PFS due in Q4

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Sovereign's Kasiya project gains momentum, as Rio increases investment by 19.76%

Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News